The aim of the study is to compare the usefulness of the determination of CEA and TATI in patients with endometrial cancer in whom occurrence of recurrence or distant metastasis of cancer was diagnosed in the course of observation after treatment. This evidence concerns the gene CEACAM5 and endometrial cancer.